These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37541371)

  • 1. Liver X receptors: From pharmacology to nanoparticle-based drug delivery.
    Hua X; Wei X
    Eur J Pharmacol; 2023 Oct; 956():175953. PubMed ID: 37541371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.
    Jakobsson T; Treuter E; Gustafsson JÅ; Steffensen KR
    Trends Pharmacol Sci; 2012 Jul; 33(7):394-404. PubMed ID: 22541735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptors as potential therapeutic targets in atherosclerosis.
    Zhu Y; Li Y
    Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor: a potential target in the treatment of atherosclerosis.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Opin Ther Targets; 2022 Jul; 26(7):645-658. PubMed ID: 36003057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting liver X receptors in inflammation.
    Steffensen KR; Jakobsson T; Gustafsson JÅ
    Expert Opin Ther Targets; 2013 Aug; 17(8):977-90. PubMed ID: 23738533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of liver-X-receptor α but not liver-X-receptor β protects against myocardial ischemia/reperfusion injury.
    He Q; Pu J; Yuan A; Lau WB; Gao E; Koch WJ; Ma XL; He B
    Circ Heart Fail; 2014 Nov; 7(6):1032-41. PubMed ID: 25277999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).
    Li X; Yeh V; Molteni V
    Expert Opin Ther Pat; 2010 Apr; 20(4):535-62. PubMed ID: 20302451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of LXR.
    Michael LF; Schkeryantz JM; Burris TP
    Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
    Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
    J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X receptor in cholesterol metabolism.
    Zhao C; Dahlman-Wright K
    J Endocrinol; 2010 Mar; 204(3):233-40. PubMed ID: 19837721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.
    Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S
    Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.
    Beyer C; Huang J; Beer J; Zhang Y; Palumbo-Zerr K; Zerr P; Distler A; Dees C; Maier C; Munoz L; Krönke G; Uderhardt S; Distler O; Jones S; Rose-John S; Oravecz T; Schett G; Distler JH
    Ann Rheum Dis; 2015 Jun; 74(6):1317-24. PubMed ID: 24618263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.
    Fessler MB
    Pharmacol Ther; 2018 Jan; 181():1-12. PubMed ID: 28720427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.
    Zhang XQ; Even-Or O; Xu X; van Rosmalen M; Lim L; Gadde S; Farokhzad OC; Fisher EA
    Adv Healthc Mater; 2015 Jan; 4(2):228-36. PubMed ID: 25156796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
    Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).
    Loren J; Huang Z; Laffitte BA; Molteni V
    Expert Opin Ther Pat; 2013 Oct; 23(10):1317-35. PubMed ID: 23826715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LXR{beta} is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux.
    Hessvik NP; Boekschoten MV; Baltzersen MA; Kersten S; Xu X; Andersén H; Rustan AC; Thoresen GH
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E602-13. PubMed ID: 19996385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptors interfere with the deleterious effect of diethylstilbestrol on testicular physiology.
    Oumeddour A; Viennois E; Caira F; Decourbey C; Maqdasy S; Tahraoui A; Baron S; Volle DH; Lobaccaro JM
    Biochem Biophys Res Commun; 2014 Apr; 446(3):656-62. PubMed ID: 24333430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.